Navigation Links
GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance : – Developing First-in-Class Endosomal TLR Inhibitors for Autoimmune and Inflammatory Diseases –
Date:12/17/2008

ed pipeline of novel Toll-like Receptor (TLR) product candidates. Based on Dynavax's proprietary technology platform, these products specifically modify the innate immune response to infectious, respiratory, autoimmune, and inflammatory diseases. Dynavax's product programs are supported by global partnerships with leading pharmaceutical companies such as Merck & Co., Inc., GlaxoSmithKline, and AstraZeneca AB, as well as funding from Symphony Dynamo, Inc. and the National Institutes of Health. For more information visit www.dynavax.com.

Dynavax Forward-Looking Statement

This press release contains "forward-looking statements," including statements related to the potential value of payments that may be received under our collaboration with GSK, the anticipated development of our inhibitors of endosomal TLRs, the future responsibilities of the parties under the collaboration agreement and Dynavax's ability to perform under the terms of the collaboration agreement. Actual results may differ materially from those set forth in this press release due to the risks and uncertainties inherent in our business, including difficulties or delays in discovery or development, initiation and completion of preclinical or clinical studies, the results of those studies and the impact of those results on the initiation and completion of subsequent studies and issues arising in the regulatory process; achieving our GSK collaborative agreement objectives; our ability to obtain additional financing to support our operations; and other risks detailed in the "Risk Factors" section of our Quarterly Report on Form 10-Q. We undertake no obligation to revise or update information herein to reflect events or circumstances in the future, even if new information becomes available.

About GlaxoSmithKline

GlaxoSmithKline - one of the world's leadin
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
2. GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of LF Program
3. GlaxoSmithKline to Acquire the Leading Dry Mouth Brand, Biotene
4. AUDIO from Medialink and GlaxoSmithKline: Give Kids A Boost For Their Health!
5. GlaxoSmithKline Acquires Sirtris Pharmaceuticals, Inc., a World Leader in Sirtuin Research and Development
6. Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
7. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
8. Video: GlaxoSmithKline Consumer Healthcare Offers Free Nicotine Lozenges for All Certified Pilots and Air Traffic Controllers to Help Them Safely Quit Smoking
9. GlaxoSmithKline Announces $500,000 in Fellowships at Stanford Graduate School of Business
10. IADR and GlaxoSmithKline Consumer Healthcare announce winners
11. A Statement from GlaxoSmithKline Consumer Healthcare on 2008 Update to the U.S. Public Health Service Guideline on Treating Tobacco Use and Dependence
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance :  – Developing First-in-Class Endosomal TLR Inhibitors for Autoimmune and Inflammatory Diseases – 
(Date:12/25/2014)... The click strand woven bamboo flooring ... Today, the business announces a click strand woven ... 30, 2015. , Click strand woven bamboo flooring ... a well-known brand in the bamboo industry. It ... reliable bamboo flooring supplier. , “We are happy ...
(Date:12/25/2014)... 26, 2014 The report “TS-1 (Colorectal ... on the current treatment landscape, unmet needs, current pipeline ... is an anti-cancer drug which is typically used for ... also used for treating gastric cancer and pancreatic cancer. ... The drug was first approved in 1999 in Japan ...
(Date:12/25/2014)... “Every three months the trends for ... evening dress will be one of the hottest styles in ... says. Today, the company releases 26 A-line sweetheart evening dresses, ... off. , “We are trying our best to help ... latest designs. Along with affordable prices, we provide discounted delivery ...
(Date:12/25/2014)... Dylan Queen, a famous online company supplying women’s special ... prom dresses, most of which are priced under $200. ... the promotion is valid until Jan. 22, 2015; the ... market. , The prom dresses in this new collection ... strapless, empire strapless chiffon, one shoulder, floor-length, V-neck beading, ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Recently, ... discounts on all its wedding dresses. BellasDress has chosen ... more for gift choices for the holiday season. ... can pick suitable wedding gowns here at discount prices. ... shopping experience at its website. , “All ...
Breaking Medicine News(10 mins):Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2
... Governor has ignored their cost saving suggestionsHARRISBURG, Pa., Jan. ... suggestions on closing the state,s budget shortfall, SEIU Local ... workers across Pennsylvania, said they have identified millions of ... Governor should cancel contracts with private contractors for work ...
... craving a delicious frozen treat that won,t pack ... option at many local chain stores -- Skinny ... company, a manufacturer of innovative sports and nutritional ... distributors, retailers and online marketers nationwide.Skinny Dippers -- ...
... -- While some emerging technologies can create environments that ... researcher thinks games like Nintendo,s Wii Fit can help ... all ages. , "I think there is a great ... technology," said David Dzewaltowski, professor and head of the ...
... Gen-Probe Incorporated (Nasdaq: GPRO ) announced today that ... Healthcare Conference on Wednesday, January 14, 2009 at 3 p.m. ... to be webcast live and may be accessed through a ... www.gen-probe.com . The webcast will be available for 30 days ...
... DIEGO, Jan. 6 Amylin Pharmaceuticals, Inc. (Nasdaq: ... Healthcare Conference in San Francisco on Monday, January 12, ... Daniel M. Bradbury, president and chief executive officer ... live presentation and breakout session will be webcast, and ...
... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... SB1518, an orally available, potent, and selective inhibitor of Janus ... S*BIO Pte Ltd based in Singapore. Under the terms ... develop and commercialize SB1518 (designated by Onyx as ONX 0803) ...
Cached Medicine News:Health News:State Human Services Union Identifies Ways to Save Millions of Tax Dollars 2Health News:Skinny Dippers(TM), First Zero-Calorie Frozen Dessert, Earns Widespread Retail, Online Distribution 2Health News:Wii Fit a promising tool for all ages 2Health News:Wii Fit a promising tool for all ages 3Health News:Gen-Probe to Webcast Presentation at the 27th Annual J.P. Morgan Healthcare Conference 2Health News:Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO 2Health News:Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO 3Health News:Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO 4
(Date:12/24/2014)... FARMINGTON, Conn. , Dec. 24, ... PTN), a biopharmaceutical company developing targeted, receptor-specific peptide ... unmet medical need and commercial potential, today announced ... of 2,050,000 shares of its common stock and ... its common stock.  Funds under the management of ...
(Date:12/24/2014)... Wis. , Dec. 23, 2014 PuraMed ... marketer of over-the-counter (OTC) medicinal and healthcare products, announced ... of MigraPure® H, a hemp-based, advanced headache relief product, ... dispensaries in Colorado , ... . With the MigraPure H Advanced headache ...
(Date:12/24/2014)... Wash. , Dec. 23, 2014  Advanced ... development company engaged primarily in the development of ... therapeutic applications, today announced that it has filed ... Food and Drug Administration ("FDA") for marketing clearance ... Section 513(f)(2) of the U.S. Food, Drug and ...
Breaking Medicine Technology:Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3
... Fla., Jan. 6, 2011 NaturaNectar LLC , ... long-term Partnership with Scandinavian based PRC - Propolis Research ... USA through a revolutionary yet time proofed technology capable ... today through a combination of a well kept extraction ...
... 6, 2011 The U.S. Food and Drug Administration ... for Industry ( www.fda.gov/FDABasicsforIndustry ) to help companies and ... the agency. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... process, including information that is frequently requested by industry. ...
Cached Medicine Technology:Breakthrough Standardized Bee Propolis Extracts Now Available Through NaturaNectar LLC Natural Supplements 2FDA Launches Website To Help Regulated Industries Save Time, Resources 2FDA Launches Website To Help Regulated Industries Save Time, Resources 3
Inquire...
Inquire...
... carefully inspects your equipment upon arrival. Our technician ... and provides you with a thorough customer quote. ... a tight budget so well help you prioritize ... repair begins., , ISI uses only OEM or ...
... The Infinity™ ALT single liquid ... in vitro quantitative determination of ALT ... patented formulation not only provides excellent ... precision and correlation against existing assays. ...
Medicine Products: